Switch to:
More From Other Websites
UK Study Indicates That The Cardiovascular Risk Of Celebrex No Different From Other Pain Drugs Sep 02 2015
Pfizer's Effort to Toss Medicaid Lawsuit Seemingly Unsuccessful Sep 01 2015
Should You Sell GE, AT&T, Pfizer? Check Weekly Charts Aug 31 2015
The 4 Stocks That Hobbled the Dow on Monday Aug 31 2015
5 Dividend Stocks With Upside Potential: Apple Inc. (AAPL), Microsoft Corporation (MSFT) & More Aug 31 2015
20 Healthcare Stocks The Richest Hedge Fund Billionaires Are Buying And Selling Now Aug 31 2015
The Zacks Analyst Blog Highlights: 3M Company, General Electric, Intel and Johnson & Johnson Aug 31 2015
Navigating through Volatility Aug 31 2015
Pfizer (PFE) Gains on Label Expansion Efforts for Ibrance Aug 28 2015
The 4 Stocks That Held Down the DJIA on Friday Aug 28 2015
What You Need To Know About 2 New S&P 500 Members Aug 28 2015
Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside Aug 28 2015
Dow 30 Stock Roundup: 3M Lowers 2015 Earnings Outlook, JNJ Subsidiary Sells Splenda Aug 28 2015
Research and Markets: China Latanoprost Market Investigation Report 2010-2019 Aug 28 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
FDA proposes adding suffixes to distinguish biosimilar drug names Aug 27 2015
Cramer: China & biotech - it's complicated Aug 27 2015
Activision Blizzard, United Continental Holdings Set to Join the S&P 500 Aug 27 2015
Trade S&P 500 changes Aug 27 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 1 year ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK